Salus Group
Salus Group is a publicly traded Slovenian pharmaceutical commercialization and distribution group that represents multinational pharmaceutical, biotech, and MedTech companies across 18 Central and Eastern European markets, bundling market access, regulatory affairs, pharmacovigilance, and distribution into integrated partnerships.
- Company typePublic
- Founded1969
- HeadquartersLjubljana, Slovenia
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingServices
What Salus Group does
Salus Group (legal entity SALUS, Ljubljana, d.d.) is a publicly traded Slovenian pharmaceutical commercialization and distribution group operating across 18 Central and Eastern European markets. Founded in 1969 and listed on the Ljubljana Stock Exchange in 1992 under ticker SALR, the company employs more than 700 experts and reported FY2025 consolidated revenue of €696 million. Its core offering is an integrated platform that represents multinational pharmaceutical, biotech, and MedTech principals in CEE markets, bundling market access, regulatory affairs, pharmacovigilance, medical affairs, marketing and sales, and physical distribution into a single outsourcing relationship.
The business is organized around three operational pillars: (1) Commercial Partnerships representing multinationals such as Pfizer, MSD/Merck, Biogen, Amicus Therapeutics, Organon, Recordati, Ferring, Angelini, Orphalan, Neuraxpharm, Abbott, Alcon, Zoetis, and Elanco across CEE; (2) Wholesale distribution through the SALUS Veletrgovina subsidiary and regional CARSO pharm entities in Slovenia, Montenegro, Bosnia and Herzegovina, Lithuania, and Albania, supplying pharmacies, hospitals, healthcare institutions, and veterinary practices; and (3) Retail through the wholly-owned Sanolabor chain of 40+ specialty stores plus the sanolabor.si online store, selling OTC products, medical devices, dietary supplements, orthopedic footwear, and consumer health products directly to Slovenian consumers. Supporting technology includes the eSalus Plus B2B ordering platform for partners, a 24-hour pharmacovigilance contact system, and dedicated infrastructure for NP/MRP/DCP/CP regulatory procedures.
Revenue is generated through wholesale transaction margins on pharmaceutical and medical device distribution, professional service fees for market access, regulatory affairs, pharmacovigilance, and medical affairs work, and retail markups on Sanolabor consumer products. The company has pursued a consistent inorganic growth strategy through acquisitions (Sanolabor in 2018, BENIFARM and MEDIFIT in 2020, MEDORION and MEDITRADE in 2023, FARMADENT in 2025) and regional entity establishment (CARSO pharm network), combined with selective portfolio rationalization (FARMEDICA divestiture in 2026). The group is governed by a two-tier Management Board and Supervisory Board structure with CEO Žiga Hieng (CFA) leading the Management Board, and operates as a public limited company with no controlling parent entity.
Salus Group firmographics
Firmographics- Name
- Salus Group
- Legal name
- SALUS, Ljubljana, d.d.
- Website
- https://salus.eu
- Company type
- Public
- Founded year
- 1969
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Salus Group is a publicly traded Slovenian pharmaceutical commercialization and distribution group that represents multinational pharmaceutical, biotech, and MedTech companies across 18 Central and Eastern European markets, bundling market access, regulatory affairs, pharmacovigilance, and distribution into integrated partnerships.
- Ownership category
- akta.pro rank
Where Salus Group is headquartered
LocationHeadquarters
- HQ city
- Ljubljana
- HQ country
- Slovenia
- HQ region
- Europe
Offices1 record
Markets served
Salus Group business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others
Revenue model
- Wholesale Distribution: Reliable, safe and efficient supply of pharmaceutical products, medical devices, sanitary materials, dietary supplements, cosmetics, pharmaceutical packaging, and other health products to pharmacies, hospitals, healthcare centers, veterinary institutions and other partners
- Commercial Partnerships: Revenue from representing multinational pharmaceutical companies in CEE markets, including market access services, regulatory affairs, medical affairs, marketing and sales services
- Retail Sales: Retail sales through Sanolabor specialized stores and online platform offering OTC products, medical devices, dietary supplements, orthopedic footwear, and healthy lifestyle products to end consumers
- Market Access Services: Data-driven market entry services including optimal pricing positioning, efficient reimbursement inclusion, and timely sustainable patient access to innovative therapies
- Regulatory and Pharmacovigilance Services: Comprehensive regulatory affairs services for human and veterinary medicines, medical devices, and food supplements, plus pharmacovigilance and medical device vigilance services
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Salus Group product offering
Product offeringCore offering
Salus Group is an integrated pharmaceutical commercialization and distribution partner for Central and Eastern Europe (CEE). It represents multinational pharmaceutical, biotech, and MedTech companies across 18 CEE markets, providing commercial partnerships, wholesale distribution, and value-added services including market access, regulatory affairs, pharmacovigilance, medical affairs, and marketing/sales. It also operates Sanolabor, the largest network of specialized pharmacy/medical device retail stores in Slovenia (40+ locations and online).
Product overview
Salus Group operates as an integrated pharmaceutical commercialization and distribution partner for Central and Eastern Europe. The company offers a unified platform of services comprising commercial partnerships (representing multinationals in CEE), wholesale distribution, and specialized retail through Sanolabor stores. Service modules include Market Access (pricing and reimbursement strategies), Regulatory Affairs and Pharmacovigilance, Marketing and Sales, Medical Affairs, and Distribution in CEE. The company serves four therapeutic portfolios: RX and Rare Diseases (neurology, endocrinology, cardiology, etc.), Consumer Healthcare (OTC products, supplements, medical devices), Medical Devices and Diagnostics (laboratory, renal, surgical, radiology equipment), and Animal Health (veterinary products). Key products include Pepaxti® (via Oncopeptides partnership) for multiple myeloma treatment.
Differentiator
Problem solved
Functional benefit
Brands
- Sanolabor: Largest network of specialized stores in Slovenia offering medical devices, OTC products, food supplements, orthopaedic footwear and healthy lifestyle products
- Salus Animal Health
- Salus+ Magazine
- Market Access Services
Products and services
- Commercial Partnerships Representation of multinational pharmaceutical, biotech, and MedTech companies in Central and Eastern European markets, providing integrated commercialization services including market access, regulatory affairs, medical affairs, marketing, and sales. Targeted at multinational pharmaceutical companies seeking CEE market entry.
- Pharmaceutical Wholesale Reliable, safe, and efficient supply of pharmaceutical products, medical devices, sanitary materials, dietary supplements, cosmetics, and pharmaceutical packaging to pharmacies, hospitals, healthcare centers, veterinary institutions, and other partners in Slovenia.
- Market Access Services Data-driven market entry services including optimal pricing positioning, efficient reimbursement inclusion, and timely sustainable patient access to innovative therapies across CEE markets. For pharmaceutical companies launching products in CEE.
- Regulatory Affairs and Pharmacovigilance Regulatory services for human and veterinary medicines, medical devices, and food supplements covering national procedures (NP), mutual recognition procedures (MRP), decentralized procedures (DCP), centralized procedures (CP), plus 24-hour pharmacovigilance, adverse event reporting, SOP preparation, and regulatory authority communication.
- Marketing and Sales Services Marketing communication and sales services including digital advertising in pharmacies, the Salus+ magazine (print and digital), telemarketing to pharmacies and specialized stores, and field sales team contact with channel partners.
- Medical Affairs Services Medical strategy development, scientific communication, key opinion leader (KOL) engagement, advisory board organization, and healthcare professional communication review for partner pharmaceutical companies.
- Distribution in CEE Pharmaceutical product distribution across 18 Central and Eastern European markets via established regional distribution hubs in Slovenia with long-standing partnerships with local distributors ensuring end-customer delivery.
- Sanolabor Retail
- Salus Animal Health Specialized division within Salus Wholesale dedicated to veterinary product distribution, supporting veterinary practices, clinics, hospitals, farms, and pet stores with companion animal and livestock health products from partners such as Zoetis and Elanco.
- Pepaxti (Multiple Myeloma Therapy)
Quantifiable outcome
- 20+ innovative medicines successfully included in reimbursement systems in CEE countries in the last two years
- +2 more outcomes
Companies that use Salus Group
Customer profileNamed customers16 records
Segments5 records
Ideal customer profiles3 records
Salus Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Salus Group partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered core and minor.
- OncopeptidescoreSalus Group partnered with Oncopeptides to expand access to Pepaxti® (targeted therapy for multiple myeloma) across Central and Eastern Europe. This partnership enables patients in CEE who have exhausted existing treatment options to access this fully approved innovative therapy, addressing the gap between regulatory approval and actual patient access in the region.
- AlconcorePartner for consumer healthcare products including OTC medicines and medical devices in CEE markets
- Amicus TherapeuticscorePartner for rare disease therapies commercialization in CEE region
- Angelini PharmacoreCommercial partnership for pharmaceutical products in CEE markets
- BiogencorePartner for neurological and specialty therapies in CEE region
- Ferring PharmaceuticalscorePartner for specialty care products commercialization in CEE markets
- MSD (Merck)corePartner for innovative medicines in CEE markets
- MerckcoreCommercial partnership for pharmaceutical products
- NeuraxpharmcorePartner for CNS (central nervous system) therapies in CEE markets
- OrganoncorePartner for women's health and other therapeutic areas
- OrphalancorePartner for rare disease treatments in CEE markets
- PfizercoreCommercial partnership for innovative medicines in CEE region
- RecordaticoreLong-standing partnership for pharmaceutical products in CEE
- AbbottcorePartner for medical devices and diagnostics in CEE markets
- ZoetiscorePartner for animal health products distribution in Slovenia
- ElancocorePartner for animal health products in Slovenian market
- JamiesonminorPartner for consumer healthcare (dietary supplements) products
- ReckittminorPartner for consumer healthcare products
- VantiveminorPartner for renal care medical devices
- BaxterminorPartner for medical devices including dialysis solutions
- Karl StorzminorPartner for surgical and endoscopic instruments
- Health Insurance Institute of SloveniacoreSanolabor is a contractual partner of the Health Insurance Institute of Slovenia (ZZZS), ensuring that high-quality medical and orthopedic devices prescribed by physicians are available to insured persons in Sanolabor stores, either on permanent ownership or rental basis
Scale indicators6 records
Recent moves16 records
Expansion highlights6 records
Salus Group competitors and assessment
Company assessmentRegional players
- Sopharma Trading: Sopharma Trading is a leading Bulgarian pharmaceutical distributor and part of the Sopharma Group, serving pharmacies, hospitals, and healthcare institutions primarily in Bulgaria and the Balkans. Comparable to Salus as a CEE regional pharma wholesaler with similar customer mix and product categories.
- Zentiva: Zentiva is a European generics pharmaceutical company headquartered in Prague with strong CEE roots and operations across multiple European markets. Comparable to Salus in CEE pharmaceutical market coverage and pharmacy/hospital distribution, though with a generics manufacturing core.
- Hemofarm (STADA Group): Hemofarm is a leading Serbian pharmaceutical manufacturer and distributor, part of the STADA Group, with strong presence across the Western Balkans and CEE. Comparable to Salus in CEE pharma distribution, though Hemofarm's primary orientation is manufacturing rather than third-party commercialization.
- Richter Gedeon: Richter Gedeon is a major Hungarian pharmaceutical company with significant CEE, CIS, and Western European presence, active in branded generics, specialty, and women's health. Comparable to Salus in CEE pharmaceutical market access and commercial reach, though anchored in proprietary products.
- Egis Pharmaceuticals: Egis Pharmaceuticals is a Hungarian-based pharmaceutical company with manufacturing and distribution across CEE and CIS markets. Comparable to Salus in CEE pharmaceutical distribution and market access, though vertically integrated into manufacturing rather than a pure commercialization partner.
Direct peers
- McKesson Europe (formerly Celesio/Lloyds Pharmacy): McKesson Europe operates pharmaceutical wholesale and retail pharmacy businesses across continental Europe, including CEE markets. Overlaps with Salus on wholesale distribution and pharma services, though with a broader and more mature European footprint.
- PHOENIX Group: PHOENIX Group is the largest pharmaceutical wholesaler in Europe, operating across more than 27 countries with integrated pharmacy retail and pharma services. Directly comparable to Salus as a pan-European pharma distribution and services platform, though at materially larger scale.
- Alliance Healthcare (Walgreens Boots Alliance): Alliance Healthcare is the European pharmaceutical wholesale and distribution arm of Walgreens Boots Alliance, operating across multiple European markets including Central and Eastern Europe. Comparable to Salus in wholesale, distribution, and value-added services for pharma manufacturers.
Broad incumbents
- Mediq: Mediq is a European healthcare services and medical device distribution company operating across multiple countries. Comparable to Salus in medical device distribution and broader healthcare product distribution, though Mediq focuses more on direct-to-patient and provider channels.
- Cencora (formerly AmerisourceBergen): Cencora is one of the largest global pharmaceutical distribution and services companies, providing wholesale, specialty distribution, and commercialization services. Comparable to Salus in the integrated pharma commercialization model, though operating at massive global scale rather than regionally.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
Salus Group social profiles
Digital presenceSalus Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Salus Group leadership team
Management profileNumber of profiles
Profiles5 records
Salus Group subsidiaries and ownership
Company hierarchySubsidiaries14 records
Salus Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Salus Group M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Salus Group
What does Salus Group do?
Salus Group is an integrated pharmaceutical commercialization and distribution partner for Central and Eastern Europe (CEE). It represents multinational pharmaceutical, biotech, and MedTech companies across 18 CEE markets, providing commercial partnerships, wholesale distribution, and value-added services including market access, regulatory affairs, pharmacovigilance, medical affairs, and marketing/sales. It also operates Sanolabor, the largest network of specialized pharmacy/medical device retail stores in Slovenia (40+ locations and online).
Is Salus Group a public or private company?
Salus Group is a public company. It is classified as public and is currently operating.
When was Salus Group founded?
Salus Group was founded in 1969. It employs 501 to 1,000 people.
Where is Salus Group based?
Salus Group is headquartered in Ljubljana, Slovenia, in the Europe region.
How does Salus Group make money?
Five revenue lines are on record. Wholesale Distribution is the primary driver. The others are commercial Partnerships, retail Sales, market Access Services and regulatory and Pharmacovigilance Services.
Who are Salus Group's main competitors?
Regional players on record are Sopharma Trading, Zentiva, Hemofarm (STADA Group), Richter Gedeon and Egis Pharmaceuticals. Direct peers are McKesson Europe (formerly Celesio/Lloyds Pharmacy), PHOENIX Group and Alliance Healthcare (Walgreens Boots Alliance). Broad incumbents are Mediq and Cencora (formerly AmerisourceBergen).
Does Salus Group have an API?
No public API is recorded for Salus Group.